Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.0937
-0.0089 (-8.67%)
At close: Nov 6, 2026, 4:00 PM EST
0.0955
+0.0018 (1.92%)
After-hours: Nov 6, 2026, 7:39 PM EST
Vivos Therapeutics Employees
Vivos Therapeutics had 270 employees as of March 31, 2026. The number of employees increased by 2 or 0.75% since the number was last reported on December 31, 2025. That makes Vivos Therapeutics the 24,638th largest employer in the world and 3,158th in the United States.
Employees
270
Change
2
Growth
0.75%
Revenue / Employee
$77,415
Profits / Employee
-$94,281
Market Cap
1.89M
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 270 | 2 | 0.75% | 270 | 0 |
| Dec 31, 2025 | 268 | 159 | 145.87% | 268 | 0 |
| Dec 31, 2024 | 109 | -14 | -11.38% | 109 | 0 |
| Dec 31, 2023 | 123 | -40 | -24.54% | 114 | 9 |
| Dec 31, 2022 | 163 | -4 | -2.40% | 154 | 9 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| WORK Medical Technology Group LTD | 238 |
| Baird Medical Investment Holdings | 146 |
| Co-Diagnostics | 115 |
| VolitionRx | 57 |
| Beyond Air | 54 |
| INVO Fertility | 42 |
| Adagio Medical Holdings | 41 |
| Nuwellis | 38 |
VVOS News
- 6 days ago - Vivos Therapeutics Proxy statement: Proxy filing - Filings
- 10 days ago - Vivos Therapeutics Proxy statement: Proxy filing - Filings
- 18 days ago - Vivos Therapeutics regains Nasdaq stockholders’ equity compliance - TheFly
- 18 days ago - Vivos Therapeutics Proxy statement: Proxy filing - Filings
- 18 days ago - Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders' Equity Standard - GlobeNewsWire
- 20 days ago - Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel - GlobeNewsWire
- 20 days ago - Vivos Therapeutics Proxy statement: Proxy filing - Filings
- 24 days ago - Vivos Therapeutics to acquire 11% stake in SOD Sciences for $12M in preferred - TheFly